(2018) Host Restriction Factors APOBEC3G3F and Other Interferon-Related Gene Expressions Affect Early HIV-1 Infection in Northern Pig-Tailed Macaque (Macaca leonina).

(2021) Tree Shrew as an Emerging Small Animal Model for Human Viral Infection: A Recent Overview.

(2017) APOBEC3H structure reveals an unusual mechanism of interaction with duplex RNA.

(2009) Nef proteins from simian immunodeficiency viruses are tetherin antagonists.

(2018) Baboon CD8 T cells suppress SIVmac infection in CD4 T cells through contact-dependent production of MIP-1alpha, MIP-1beta, and RANTES.

(2019) Mucosal Vaccine Approaches for Prevention of HIV and SIV Transmission.

(1998) HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors.

(2022) Restriction of Influenza A Virus by SERINC5.

(2018) CXCR4- and CCR5-Tropic HIV-1 Clones Are Both Tractable to Grow in Rhesus Macaques.

(2012) Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA.

(2012) Long-term infection and vertical transmission of a gammaretrovirus in a foreign host species.

(2020) Major Scientific Hurdles in HIV Vaccine Development: Historical Perspective and Future Directions.

(2018) High throughput generation and characterization of replication-competent clade C transmitter-founder simian human immunodeficiency viruses.

(2009) Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants.

(2008) A single site for N-linked glycosylation in the envelope glycoprotein of feline immunodeficiency virus modulates the virus-receptor interaction.

(2021) Extracellular Vesicles Generated by Gram-Positive Bacteria Protect Human Tissues Ex Vivo From HIV-1 Infection.

(2015) The KT Jeang Retrovirology prize 2015: Paul Bieniasz.

(2010) The Vpu protein: new concepts in virus release and CD4 down-modulation.

(2020) Macrophage Tropism in Pathogenic HIV-1 and SIV Infections.

(2009) Modification of a loop sequence between alpha-helices 6 and 7 of virus capsid (CA) protein in a human immunodeficiency virus type 1 (HIV-1) derivative that has simian immunodeficiency virus (SIVmac239) vif and CA alpha-helices 4 and 5 loop ...

(2022) The HIV Env Glycoprotein Conformational States on Cells and Viruses.

(2019) Rational design and in vivo selection of SHIVs encoding transmittedfounder subtype C HIV-1 envelopes.

(2017) Conserved HIV Epitopes for an Effective HIV Vaccine.

(2015) Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques.

(2023) Genomic Evidence for the Nonpathogenic State in HIV-1-Infected Northern Pig-Tailed Macaques.

(2021) Tree Shrew Cells Transduced with Human CD4 and CCR5 Support Early Steps of HIV-1 Replication, but Viral Infectivity Is Restricted by APOBEC3.

(2017) Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field.

(2022) SERINC5 restricts influenza virus infectivity.

(2020) Helping koalas battle disease - Recent advances in Chlamydia and koala retrovirus (KoRV) disease understanding and treatment in koalas.

(2015) Single amino acid substitution (G42E) in the receptor binding domain of mouse mammary tumour virus envelope protein facilitates infection of non-murine cells in a transferrin receptor 1-independent manner.

(2013) Nonhuman primate models for HIVAIDS vaccine development.

(2012) TRIM5alpha and Species Tropism of HIVSIV.

(2007) Cytopathic mechanisms of HIV-1.

(2007) Disparate effects of acute and chronic infection with SIVmac239 or SHIV-89.6P on macaque plasmacytoid dendritic cells.

(2023) The Antiviral Factor SERINC5 Impairs the Expression of Non-Self-DNA.

(2019) Exploitation of glycosylation in enveloped virus pathobiology.

(2023) Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV.

(2018) Meeting Review: 2018 International Workshop on Structure and Function of the Lentiviral gp41 Cytoplasmic Tail.

(2009) Strategies for targeting tetraspanin proteins: potential therapeutic applications in microbial infections.

(2021) Preclinical models for studying immune responses to traumatic injury.

(2014) Gene therapy strategies to exploit TRIM derived restriction factors against HIV-1.

(2013) HERV-K(HML-2), the Best Preserved Family of HERVs: Endogenization, Expression, and Implications in Health and Disease.

(2015) Progresses towards safe and efficient gene therapy vectors.

(2012) Breaking Barriers to an AIDS Model with Macaque-Tropic HIV-1 Derivatives.

(2022) Solving the Conundrum of Eosinophils in Alloimmunity.

(2020) Antiviral Role of Serine Incorporator 5 (SERINC5) Proteins in Classical Swine Fever Virus Infection.

(2020) Screening and identification of key regulatory connections and immune cell infiltration characteristics for lung transplant rejection using mucosal biopsies.

(2019) HUSH, a Link Between Intrinsic Immunity and HIV Latency.

(2021) HIV replication and latency in monocytes and macrophages.

(2022) Advances in HIV-1 Assembly.

(2013) Porcine neonatal blood dendritic cells, but not monocytes, are more responsive to TLRs stimulation than their adult counterparts.

(2013) Characterization of human afferent lymph dendritic cells from seroma fluids.

(2024) The menstrual cycle regulates migratory CD4 T-cell surveillance in the female reproductive tract via CCR5 signaling.

(2023) Pharmacotherapeutic profile, polypharmacy and its associated factors in a cohort of people living with HIV in Brazil.

(2022) Avian Orthoavulavirus Type-1 as Vaccine Vector against Respiratory Viral Pathogens in Animal and Human.

(2020) Melittin: a venom-derived peptide with promising anti-viral properties.

(2019) Dynamics of Vaginal and Rectal Microbiota Over Several Menstrual Cycles in Female Cynomolgus Macaques.

(2018) Recent progress in broadly neutralizing antibodies to HIV.

(2016) Nonhuman primate models for the evaluation of HIV-1 preventive vaccine strategies: model parameter considerations and consequences.

(2013) A variant macaque-tropic human immunodeficiency virus type 1 is resistant to alpha interferon-induced restriction in pig-tailed macaque CD4+ T cells.

(2012) Next generation deep sequencing and vaccine design: today and tomorrow.

(2012) Dynamics of envelope evolution in clade C SHIV-infected pig-tailed macaques during disease progression analyzed by ultra-deep pyrosequencing.

(2012) Systems biology of natural simian immunodeficiency virus infections.

(2011) Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1.

(2010) Polyvalent AIDS vaccines.

(2010) Prediction of co-receptor usage of HIV-1 from genotype.

(2008) Could FIV zoonosis responsible of the breakdown of the pathocenosis which has reduced the European CCR5-Delta32 allele frequencies?

(2008) Heavily glycosylated, highly fit SIVMne variants continue to diversify and undergo selection after transmission to a new host and they elicit early antibody dependent cellular responses but delayed neutralizing antibody responses.

(2006) The integration hypothesis: an evolutionary pathway to benign SIV infection.

(2004) Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is ...

(2003) Immunogenicity in pig-tailed macaques of poliovirus replicons expressing HIV-1 and SIV antigens and protection against SHIV-89.6P disease.

(2002) CD4+ lymphocytopenia in acute infection of Asian macaques by a vaginally transmissible subtype-C, CCR5-tropic SimianHuman Immunodeficiency Virus (SHIV).

(2020) Influenza-Host Interplay and Strategies for Universal Vaccine Development.

(2010) Plasmacytoid dendritic cells in antiviral immunity and autoimmunity.

(2019) Gene Therapy Leaves a Vicious Cycle.

(2021) Plant-Derived Antimicrobial Peptides as Potential Antiviral Agents in Systemic Viral Infections.

(2021) CRISPR-based strategies in infectious disease diagnosis and therapy.

(2020) Rhabdoviruses as vectors for vaccines and therapeutics.

(2020) The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity.

(2020) Non-Nucleoside Reverse Transcriptase Inhibitors Join Forces with Integrase Inhibitors to Combat HIV.

(2017) Potential of small-molecule fungal metabolites in antiviral chemotherapy.

(2015) An Evolutionarily Young Polar Bear (Ursus maritimus) Endogenous Retrovirus Identified from Next Generation Sequence Data.

(2015) Animal models in HIV-1 protection and therapy.

(2013) A comparative mutational analysis of HIV-1 Vpu subtypes B and C for the identification of determinants required to counteract BST-2Tetherin and enhance viral egress.

(2013) Efficient mucosal transmissibility but limited pathogenicity of R5 SHIV SF162P3N in Chinese-origin rhesus macaques.

(2013) Simian-Human immunodeficiency viruses expressing chimeric subtype BC Vpu proteins demonstrate the importance of the amino terminal and transmembrane domains in the rate of CD4(+) T cell loss in macaques.

(2012) Identification of novel subgroup A variants with enhanced receptor binding and replicative capacity in primary isolates of anaemogenic strains of feline leukaemia virus.

(2012) Animal models for microbicide studies.

(2011) Silver nanoparticles as potential antiviral agents.

(2011) MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines.

(2010) Progress in antiretroviral drug delivery using nanotechnology.

(2010) Relative replication capacity of phenotypic SIV variants during primary infections differs with route of inoculation.

(2009) HIV-1 and influenza antibodies: seeing antigens in new ways.

(2008) Differential pathogenicity of SHIV infection in pig-tailed and rhesus macaques.

(2007) Quasispecies and its impact on viral hepatitis.